ArticleBlood2025

The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathy.

Heike C Hawerkamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.